|
Chair: Ms Cristiana Monteiro, Ms Holly Daw |
|
Oxford UK, London UK |
|
|
Allied Professionals & Service Improvement |
|
|
|
08:30 |
JOINT DEVICE / VENTRICULAR TACHYCARDIA CLINIC - A SERVICE DESCRIPTION |
Christopher Monkhouse |
London UK |
|
08:45 |
HIS-BUNDLE PACING - THE FEASIBILITY OF UPGRADING OCTOGENARIANS TO HIS-BUNDLE PACING FROM STANDARD RIGHT VENTRICULAR PACING |
Ms Rachel Ferro |
Swindon UK |
|
09:00 |
ONE TERTIARY CENTRE'S OVERVIEW OF EMERGENCY TRANSVENOUS PACEMAKER IMPLANTATION SERVICE |
Hayley Langridge |
London UK |
|
09:15 |
THE INDICATIONS AND SAFETY OF PROLONGED TEMPORARY PACING USING TRANSVENOUS LEADS AND EXTERNALISED PULSE GENERATOR: A SINGLE CENTRE EXPERIENCE |
Nisar Shah |
Cardiff UK |
|
09:30 |
DELIVERING A COMPLEX CIED SERVICE VIA A DISTRICT GENERAL HOSPITAL |
James Wilson |
Croydon UK |
|
09:45 |
INNOVATIVE PATHWAY MODEL FOR THE DETECTION AND TREATMENT OF ATRIAL FIBRILLATION - THE CAPTURE AF SERVICE |
Zainab Khanbhai |
London UK |
|
10:00 |
Break |
|
|
|
|
Chair: Dr Claire Martin |
|
Cambridge UK |
|
|
AF-Clinical |
|
|
|
10:45 |
PROGNOSTIC MODEL DEVELOPMENT FOR PREVALENT ATRIAL FIBRILLATION USING INDIVIDUAL PATIENT DATA FROM EUROPEAN COHORTS: PRELIMINARY RESULTS FROM CATCH ME |
Winnie Chua |
Birmingham UK |
|
11:00 |
ANALYSIS OF PROARRHYTHMIC PHENOMENA IN ELECTROPHYSIOLOGICAL MAPPING DATASETS USING ELECTROMAP: AN OPEN-SOURCE SOFTWARE PLATFORM |
Christopher O'Shea |
Birmingham UK |
|
11:15 |
REVERSED QT-RR HYSTERESIS PREDICTS CARDVIOASCULAR OUTCOME AND DEATH IN 25228 INDIVIDUALS FROM UK BIOBANK |
Stefan van Duijvenboden |
London UK |
|
11:30 |
CONTINUOUS REDUCTION IN IRRIGATION RATE DURING IRRIGATED RADIOFREQUENCY CATHETER ABLATION RESULTS IN A MORE OPTIMISED LESION SHAPE THROUGH REDUCED ENDOCARDIAL SPARING |
Moloy Das |
Newcastle Upon Tyne UK |
|
11:45 |
CONVERGENT APPROACH TO PERSISTENT ATRIAL FIBRILLATION ABLATION: SINGLE-CENTRE SAFETY AND EFFICACY |
Alexander Carpenter |
Bristol UK |
|
12:00 |
IMPACT: IMPROVING OESOPHAGEAL PROTECTION DURING CATHETER ABLATION FOR AF. A DOUBLE BLIND RANDOMISED CONTROLLED TRIAL |
Lisa Leung |
London UK |
|
12:15 |
Close |
|
|
|
|
SESSION 1 Paediatric Brugada Syndrome & Management of Ventricular Arrhythmia |
|
|
|
|
Chair: Dr Cecilia Gonzalez, Dr John Triedman |
|
Bristol UK, Boston US |
|
08:30 |
Which diagnostic clues and investigative methods should we use in Brugada syndrome? |
Dr Robert Hamilton |
Toronto CA |
|
09:00 |
How to manage phenotype and gene positive Brugada syndrome in asymptomatic and symptomatic children? |
Dr Robert Hamilton |
Toronto CA |
|
09:30 |
Mapping and ablation principles of ventricular tachycardia in children with or without CHD |
Dr John Triedman |
Boston US |
|
09:50 |
Panel discussions/questions |
|
|
|
10:00 |
Break |
|
|
|
|
SESSION 2 Ablation accessory pathways & AVNRT |
|
|
|
|
Chair: Dr Jan Till, Dr Susan Etheridge |
|
London UK, Utah US |
|
10:45 |
Risk stratification of WPW Syndrome: updates following multicentre study results |
Dr Susan Etheridge |
Utah US |
|
11:05 |
Left Posteroseptal Accessory Pathways |
Dr John Triedman |
Boston US |
|
11:35 |
Differentiating 3 Types of Slow/Fast AVNRT |
Dr Fong Leong |
Cardiff UK |
|
12:05 |
Panel discussions/questions |
|
|
|
12:15 |
Lunch |
|
|
|
|
SESSION 3 LQT & CPVT |
|
|
|
|
Chair: Dr Juan Kaski, Prof Orhan Uzun |
|
London UK, Cardiff UK |
|
13:30 |
Current thinking on LQT syndromes: The challenges of Diagnosis and recognition of new subtypes |
Dr Juan Kaski |
London UK |
|
14:00 |
Are we too strict in exercise, activity sport recommendations of long QT, Brugada syndrome and CPVT? What is reasonable? |
Dr Susan Etheridge |
Utah US |
|
14:20 |
Current Thinking on LQT syndromes: Risk Stratification and alternative/future treatment options |
Dr Jan Till |
London UK |
|
14:50 |
Panel discussions/questions |
|
|
|
15:00 |
Break |
|
|
|
|
SESSION 4 Cardiomyopathy and JET Management |
|
|
|
|
Chair: Prof Narayanswami Sreeram, Prof Volkan Tuzcu |
|
Cologne DE, Doha QA |
|
15:45 |
Risk of sudden death in children with dilated and hypertrophic cardiomyopathy |
Prof Narayanswami Sreeram |
Cologne DE |
|
16:05 |
Emerging medical and invasive treatment options for cardiomyopathies |
Prof Volkan Tuzcu |
Doha QA |
|
16:25 |
Emerging medical and invasive treatment for postoperative JET |
Dr John Triedman |
Boston US |
|
|
Chair: Prof Narayanswami Sreeram, Prof Orhan Uzun |
|
Cologne DE, Cardiff UK |
|
|
Trainee Case Presentations: 5 cases, 5 minutes, 5 slides |
|
|
|
16:45 |
LONG-TERM OUTCOMES OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ADULTS WITH REPAIRED TETRALOGY OF FALLOT |
Sophie Jenkins |
London UK |
|
16:50 |
AETIOLOGY AND EFFICACY OF ATRIAL FIBRILLATION ABLATION IN YOUNG ADULTS |
Roy Zhang |
Cambridge UK |
|
16:55 |
4.5 YEAR SINGLE CENTRE EXPERIENCE WITH THE SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR: A COMPARISON WITH THE POST-MARKET APPROVAL STUDY |
Marie Jennyfer Ng Kam chuen |
Nottingham UK |
|
17:00 |
A SHEEP IN WOLF'S CLOTHING |
Heather Edwards |
Cardiff UK |
|
17:05 |
OUT OF HOSPITAL ARREST IN A PATIENT WITH A HOMOZYGOUS SCN1A MUTATION: CAN THIS LEAD TO AN INCREASED PREDISPOSITION TO CARDIAC ARRHYTHMIA AND SUDDEN DEATH IN CHILDHOOD |
Jennifer Shortland |
Bristol UK |
|
17:10 |
Panel discussions/questions |
|
|
|
17:15 |
Close |
|
|
|
|
Chair: Prof Richard Sutton, Prof Satish Raj |
|
Monte Carlo MC, Calgary CA |
|
|
Session 1: POTS |
|
|
|
08:30 |
POTS aetiology other than autoimmunity |
Prof Satish Raj |
Calgary CA |
|
08:50 |
Current evidence for autoimmunity in POTS |
Prof Artur Fedorowski |
Lund SW |
|
09:10 |
Are we making progress in POTS management? |
Prof Lesley Kavi |
Birmingham UK |
|
09:30 |
Alternative strategies in POTS treatment |
Dr Nick Gall |
London UK |
|
09:50 |
Panel discussions/questions |
|
|
|
10:00 |
Break |
|
|
|
10:45 |
Risk stratification of syncope in the ED |
Dr Robert Sheldon |
Calgary CA |
|
11:15 |
Alternative therapeutic strategies for VVS |
Dr Boon Lim |
London UK |
|
11:45 |
Is there a role for ablation in VVS? |
Prof Richard Sutton |
Monte Carlo MC |
|
12:05 |
Panel discussions/questions |
|
|
|
12:15 |
Lunch |
|
|
|
|
Chair: Dr Boon Lim, Dr Nick Gall |
|
London UK, London UK |
|
|
Session 2: Syncope Units |
|
|
|
13:30 |
STARS update |
Mrs Trudie Lobban MBE |
Chipping Norton UK |
|
13:40 |
Rapid Access Blackout Clinic/Syncope Units |
Dr Nick Gall |
London UK |
|
13:55 |
Syncope Units: The Hammersmith Model |
Dr Boon Lim |
London UK |
|
14:10 |
Why haven't Canadians embraced Syncope Units? |
Dr Roopinder Sandhu |
Alberta CA |
|
14:50 |
Panel discussions/questions |
|
|
|
15:00 |
Break |
|
|
|
|
Session 3: Biomedical Therapies |
|
|
|
15:45 |
Debate: Vasovagal Syncope: Pacing? - For |
Prof Richard Sutton |
Monte Carlo MC |
|
16:05 |
Debate: Vasovagal Syncope: Pacing? - Against |
Dr Nick Gall |
London UK |
|
16:25 |
Vasovagal Syncope: POST mortem for drugs? |
Dr Robert Sheldon |
Calgary CA |
|
16:45 |
Vasovagal Syncope: Still hope for medical therapy? |
Prof Satish Raj |
Calgary CA |
|
17:05 |
Panel discussions/questions |
|
|
|
17:15 |
Close |
|
|
|
|
Chair: Dr Steve Murray |
|
Newcastle Upon Tyne UK |
|
13:30 |
Chairman’s Welcome & Opening Remarks |
Dr Steve Murray |
Newcastle Upon Tyne UK |
|
13:35 |
“Seeing it all” - How AcQMap works, who it’s for and how I include it in my workflow |
Dr Ewen Shepherd |
Newcastle Upon Tyne UK |
|
13:50 |
“The new World View for AF ablation” - What AcQMap has taught me about AF mechanisms and how that guides my procedure |
Dr Tim Betts |
Oxford UK |
|
14:05 |
“Seeking A New Normal” - Complex Arrhythmia Treatment through the Integration of New & Developing Technology |
Prof Sabine Ernst |
London UK |
|
14:20 |
“Individualised Lesion Sets are Superior to Empiric Treatment in Persistent AF” – Debate |
|
|
|
|
Protagonist: |
Dr Mark Norman |
Frimley UK |
|
|
Antagonist: |
Dr Nick Kelland |
Sheffield UK |
|
|
Rebuttal & Audience ‘show of hands’ |
|
|
|
14:50 |
Panel Discussion & Closing Remarks |
|
|
|
15:00 |
Close |
|
|
|
|
Chair: Dr Fu Siong Ng |
|
London UK |
|
|
Judges |
Dr Fu Siong Ng, Prof Neil Herring, Prof Paulus Kirchhof, Prof Pier Lambiase |
London UK, Oxford, UK, Birmingham UK, London UK |
|
|
Basic Science |
|
|
|
13:30 |
GAP JUNCTION MODULATION IS A MAJOR DETERMINANT OF THE MECHANISM AND ORGANISATION OF VENTRICULAR FIBRILLATION AND A POTENTIAL THERAPEUTIC TARGET |
Balvinder Handa |
London UK |
|
14:00 |
CD4+ T-CELL PRIMING AS A DRIVER OF EPICARDIAL ADIPOSE TISSUE MEDIATED ATRIAL FIBRILLATION |
Vishal Vyas |
London UK |
|
14:30 |
LEFT ATRIAL CARDIOMYOCYTE PITX2 EXPRESSION PREDICTS RECURRENT ATRIAL FIBRILLATION AFTER ATRIAL FIBRIALLATION ABLATION IN PATIENTS |
Jasmeet Reyat |
Birmingham UK |
|
15:00 |
Break |
|
|
|
|
Judges |
Dr Fu Siong Ng, Prof Neil Herring, Prof Paulus Kirchhof, Prof Sabine Ernst |
London UK, Oxford, UK, Birmingham UK, London UK |
|
|
Clinical Science |
|
|
|
15:45 |
THE IMPACT OF ATRIAL FIBRILLATION TYPE ON RISKS OF STROKE AND SYSTEMIC EMBOLISM MAJOR HAMEORRHAGE AND MORTALITY IN PATIENTS WITH PREVIOUS STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS |
Antonia Mentel |
Glasgow UK |
|
16:15 |
MAPPING AT SITES OF TERMINATION OF PERSISTENT ATRIAL FIBRILLATION BY COMPARING THREE INDEPENDENT TECHNIQUES: THE COMPARE-AF MULTICENTER STUDY |
Junaid Zaman |
London UK |
|
16:45 |
THE IMPACT OF PULMONARY VEIN ISOLATION ON MECHANISMS SUSTAINING PERSISTENT ATRIAL FIBRILLATION: PREDICTING THE ACUTE RESPONSE. |
Gurpreet Dhillon |
London UK |
|
17:15 |
Close |
|
|
|
|
Chair: Dr Marco Proietti, Prof Tatjana Potpara |
|
Milan IT; Liverpool UK, Belgrade RS |
|
|
Session 1: Management of Atrial Fibrillation: Easy as ABC |
|
|
|
13:30 |
A holistic and integrated approach to AF management: Easy as ABC |
Dr Marco Proietti |
Milan IT; Liverpool UK |
|
13:50 |
A: Avoid stroke with Anticoagulation |
Prof Ahmet Fuat |
Durham UK |
|
14:05 |
B: Better symptom management, with rate or rhythm control |
Dr Waqas Ullah |
Southampton UK |
|
14:25 |
C: Cardiovascular risk factor and comorbidity management, including lifestyle changes |
Prof Tatjana Potpara |
Belgrade RS |
|
14:40 |
The importance of P-Wave centric ECG monitoring analysis |
Dr Gust Bardy |
Seattle US |
|
15:00 |
Break |
|
|
|
|
Session 2: AF and Heart Failure: current controversies |
|
|
|
|
Chair: Prof Martin Cowie, Dr Wyn Davies |
|
London UK, London UK |
|
15:45 |
Ablation after CASTLE-AF and CABANA: are we any the wiser? |
Dr Wyn Davies |
London UK |
|
16:05 |
Are beta-blockers of benefit in patients with AF and HF? |
Prof Martin Cowie |
London UK |
|
16:25 |
Does CRT work in patients with AF? |
Prof Derek Connelly |
Glasgow UK |
|
16:45 |
And do we even anticoagulate appropriately? |
Prof Martin Cowie |
London UK |
|
17:05 |
Panel discussions/questions |
|
|
|
17:15 |
Close |
|
|
|
|
Chair: Dr Malcolm Finlay, Prof Prapa Kanagaratnam |
|
London, UK, London UK |
|
15:00 |
A COMPARISON OF ARRHYTHMIA NURSE SPECIALISTS VERSUS CLINICIANS SYNCOPE RISK STRATIFICATION: DIAGNOSTIC YIELD OF IMPLANTABLE LOOP RECORDERS |
Helen Eftekhari |
Coventry UK |
|
15:05 |
CHARACTERISATION OF MISSENSE VARIANTS IN RYR2 |
Damilola Olubando |
Manchester UK |
|
15:10 |
THE INCIDENCE OF NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONISATION THERAPY |
Sophie Robinson |
Birmingham UK |
|
15:15 |
TARGETED ABLATION CLUSTER TECHNIQUE (TACT) FOR ABLATION OF COMPLEX ATRIAL ARRHYTHMIAS INCONGENITAL HEART DISEASE AS GUIDED BY ULTRA-HIGH DEFINITION MAPPING |
Anna Kefala |
Southampton UK |
|
15:20 |
ANALYSIS OF PREDICTIVE FACTORS FOR PROPAFENONE PROARRHYTHMIA. DOES EXERCISE ECG PLAY A ROLE DURING LONG TERM PROPAFENONE TREATMENT? |
Peter Janos Kalmar |
Debrecen HU |
|
15:25 |
VALIDATION OF A DATA-DRIVEN BIOMARKER MODEL FOR ATRIAL FIBRILLATION IN AN UNSELECTED COMMUNITY-BASED PATIENT COHORT PRESENTING ACUTELY TO HOSPITAL |
Winnie Chua |
Birmingham UK |
|
15:30 |
ADAPTING KNOW YOUR PULSE (KYP) EVENTS TO BENEFIT YOUNG ADULTS |
Trudie Lobban MBE |
Chipping Norton UK |
|
15:35 |
SHOULD UK CARDIOLOGY DEPARTMENTS SWITCH TO USING MORE INNOVATIVE AND MINIATURISED AMBULATORY ECG MONITORING? A PATIENT REPORTED OUTCOMES ANALYSIS. |
Christopher Monkhouse |
London UK |
|
15:40 |
Q & A's |
|
|
|
15:45 |
Close |
|
|
|